The European Commission’s report on how the controversial Paediatric Regulation is working 10 years after it came into force is “a positive step forward,” but it also highlights the need to review how the procedure relating to pediatric investigation plans (PIPs) is functioning, according to a legal expert.
“The report is fairly balanced, makes sensible observations, and the commission concludes on a positive socio-economic value of the Paediatric Regulation,” Geneviève Michaux, a partner at the law firm Mayer Brown, told the Pink Sheet
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?